Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia

International Journal of Oncology

Volumn 34, Issue 6, 2009, Pages 1603-1612

  Kawamata, Norihiko ^a   Ogawa, Seishi ^b   Seeger, Karl ^c   Kirschner Schwabe, Renate ^c   Huynh, Thien ^a   Chen, John ^a   Megrabian, Nairi ^a   Harbott, Jochen ^d   Zimmermann, Martin ^e   Henze, Günter ^c   Schrappe, Martin ^f   Bartram, Claus R ^g   Koeffler, Phillip H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF KIEL   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

INK4A ARF; NF2; PTPRD; Single nucleotide polymorphism genomic microarray; Uniparental disomy

Indexed keywords

ARF PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 22Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; DNA MICROARRAY; GENE DELETION; GENE DUPLICATION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; KARYOTYPING; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MOLECULAR ALLELOKARYOTYPING; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRISOMY; UNIPARENTAL DISOMY;

ADOLESCENT; ADP-RIBOSYLATION FACTOR 1; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 22; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, NEUROFIBROMATOSIS 2; GENOME, HUMAN; HUMANS; INFANT; KARYOTYPING; LOSS OF HETEROZYGOSITY; NEOPLASM RECURRENCE, LOCAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; UNIPARENTAL DISOMY;

EID: 67649442524     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000290     Document Type: Article

References (33)

1. Pui CH, Relling MV and Downing JR: Acute lymphoblastic leukemia. N Engl J Med 350: 1535-1548, 2004.
2. Pui CH and Evans WE: Acute lymphoblastic leukemia. N Engl J Med 339: 605-615, 1998.
3. Creutzig U, Ritter J, Zimmermann M, et al: Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Munster 93. J Clin Oncol 19: 2705-2713, 2001.
4. Schrappe M, Reiter A, Ludwig WD, et al: Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95: 3310-3322, 2000.
5. Hongo T, Yajima S, Sakurai M, Horikoshi Y and Hanada R: In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood 89: 2959-2965, 1997.
6. Kaspers GJ, Veerman AJ, Pieters R, et al: In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia. Blood 90: 2723-2729, 1997.
7. Holleman A, Cheok MH, den Boer ML, et al: Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N Engl J Med 351: 533-542, 2004.
8. Lugthart S, Cheok MH, den Boer ML, et al: Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia. Cancer Cell 7: 375-386, 2005.
9. Armstrong SA, Staunton JE, Silverman LB, et al: MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia. Nat Genet 30: 41-47, 2002.
10. Borgmann A, von Stackelberg A, Hartmann R, et al: Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 101: 3835-3839, 2003.
11. Einsiedel HG, von Stackelberg A, Hartmann R, et al: Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87. J Clin Oncol 23: 7942-7950, 2005.
12. Pinkel D and Albertson DG: Array comparative genomic hybridization and its applications in cancer. Nat Genet 37: S11-S7, 2005.
13. Gunderson KL, Steemers FJ, Lee G, Mendoza LG and Chee MS: A genome-wide scalable SNP genotyping assay using microarray technology. Nat Genet 37: 549-554, 2005.
14. Nannya Y, Sanada M, Nakazaki K, et al: A robust algorithm for copy number detection using high-density oligonucleotide single nucleotide polymorphism genotyping arrays. Cancer Res 65: 6071-6079, 2005.
15. Yamamoto G, Nannya Y, Kato M, et al: Highly sensitive method for genomewide detection of allelic composition in nonpaired, primary tumor specimens by use of affymetrix single-nucleotide-polymorphism genotyping microarrays. Am J Hum Genet 81: 114-126, 2007.
16. Kawamata N, Ogawa S, Zimmermann M, et al: Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high resolution single nucleotide polymorphism oligonucleotide genomic microarray. Blood 111: 776-784, 2008.
17. Lehmann S, Ogawa S, Raynaud SD, et al: Molecular allelo-karyotyping of early stage untreated chronic lymphocytic leukemia. Cancer 112: 1296-1305, 2008.
18. Sutcliffe MJ, Shuster JJ, Sather HN, et al: High concordance from independent studies by the Children's Cancer Group (CCG) and Pediatric Oncology Group (POG) associating favorable prognosis with combined trisomies 4, 10, and 17 in children with NCI Standard-Risk B-precursor Acute Lymphoblastic Leukemia: a Children's Oncology Group (COG) initiative. Leukemia 19: 734-740, 2005.
19. Heerema NA, Sather HN, Sensel MG, et al: Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (>50 chromosomes). J Clin Oncol 18: 1876-1887, 2000.
20. Fitzgibbon J, Smith LL, Raghavan M, et al: Association between acquired uniparental disomy and homozygous gene mutation in acute myeloid leukemias. Cancer Res 65: 9152-9154, 2005.
21. Hirama T and Koeffler HP: Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841-854, 1995.
22. Mullighan CG, Goorha S, Radtke I, et al: Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia. Nature 446: 758-764, 2007.
23. Kawamata N, Ogawa S, Zimmermann M, et al: Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray. Proc Natl Acad Sci USA 105: 11921-11926, 2008.
24. Stark M and Hayward N: Genome-wide loss of heterozygosity and copy number analysis in melanoma using high-density single-nucleotide polymorphism arrays. Cancer Res 67: 2632-2642, 2007.
25. Stallings RL, Nair P, Maris JM, et al: High-resolution analysis of chromosomal breakpoints and genomic instability identifies PTPRD as a candidate tumor suppressor gene in neuroblastoma. Cancer Res 66: 3673-3680, 2006.
26. Purdie KJ, Lambert SR, Teh MT, et al: Allelic imbalances and microdeletions affecting the PTPRD gene in cutaneous squamous cell carcinomas detected using single nucleotide polymorphism microarray analysis. Genes Chromosomes Cancer 46: 661-669, 2007.
27. Sato M, Takahashi K, Nagayama K, et al: Identification of chromosome arm 9p as the most frequent target of homozygous deletions in lung cancer. Genes Chromosomes Cancer 44: 405-414, 2005.
28. Nagayama K, Kohno T, Sato M, Arai Y, Minna JD and Yokota J: Homozygous deletion scanning of the lung cancer genome at a 100-kb resolution. Genes Chromosomes Cancer 46: 1000-1010, 2007.
29. Zhao X, Weir BA, LaFramboise T, et al: Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis. Cancer Res 65: 5561-5570, 2005.
30. Uetani N, Kato K, Ogura H, et al: Impaired learning with enhanced hippocampal long-term potentiation in PTPdelta-deficient mice. EMBO J 19: 2775-2785, 2000.
31. Pulido R, Serra-Pages C, Tang M and Streuli M: The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1. Proc Natl Acad Sci USA 92: 11686-11690, 1995.
32. Haber DA and Settleman J: Cancer: drivers and passengers. Nature 446: 145-146, 2007.
33. Mullighan CG, Phillips LA, Su X, Ma J, Miller CB, Shurtleff SA and Downing JR: Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia. Science 322: 1377-1380, 2008.